期刊文献+

核转录因子FoxO1在肝糖脂质代谢中的作用 被引量:7

下载PDF
导出
摘要 肝脏是机体能量平衡,尤其是糖脂代谢的主要器官。肝糖脂代谢异常是糖尿病、肥胖、非酒精性脂肪肝等代谢综合征的主要病理要素,肝脏胰岛素抵抗则是这类疾病发病机制的主要环节。肝脏胰岛素抵抗时最明显的病理生理特点为糖原分解和糖异生增加,肝合成输出富含甘油三酯颗粒的VLDL增加,导致高血糖症和高甘油三酯血症。
作者 祝红梅 陈秋
出处 《实用医学杂志》 CAS 北大核心 2010年第24期4609-4611,共3页 The Journal of Practical Medicine
基金 四川省杰出青年科技基金项目(编号:07ZQ026-026)
  • 相关文献

参考文献18

  • 1Nakae J,Oki M,Cao Y.The FoxO transcription factors and metabolic regula-tion[J].FEBS Letters,2008,582(1):54-67.
  • 2Aclama Kamagate H.Henry Dong.FoxO1 integrates insulin signaling to VLDL production[J].Cell Cycle,2008,7(20):3162-3170.
  • 3Barthel A,Ostrakhovitch E A,Walter P L,et al.Stimulation of phosphoin-ositide 3-kinase/Akt signaling by copper and zinc ions; mechanisms and consequences[J].Arch Biochem Biophys,2007,463(2):175-827.
  • 4Puigserver P,Rhee J,Donovan J,et al.Insulin-regulated hepatic gluconeog-enesis through FOXO1-PGC-1a interaction[J].Nature,2003,423 (6939):550-555.
  • 5Matsumoto M,Han S,Kitamura T,et al.Dual role of transcription factor FoxOl in controlling hepatic insulin sensitivity and lipid metabolism[J].J Clin Invest,2006,116(9):2464-2472.
  • 6Masyuk A I,LaRusso N F.Aquaporins in the hepatobiliary system[J].Hepatology,2006,43(2):S75-81.
  • 7Elkjaer M,Vajda 2,Nejsum L N et al.Immunolocalization of AQP9 in liver,epididymis,testis,spleen,and brain[J].Biochem Biophys Res Commun,2000,276(3):1118-1128.
  • 8Zhang W,Patil S,Chauhan B,et al.FoxO1 regulates multiple metabolic pathways in the liver:effects on gluconeogenic,glycolytic,and lipogenic gene expression[J].J Biol Chem,2006,281(15):10105-101117.
  • 9Valenti L,Rametta R,Dongiovanni P.Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis[J].Diabetes,2008,57(5):1355-1362.
  • 10Hussain M,Shi J,and Dreizen P.Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly[J].J Lipid Res,2003,44 (1):22-32.

同被引文献90

  • 1吕佳,高月求,朱晓骏.高月求从脾论治非酒精性脂肪性肝病经验[J].上海中医药杂志,2020,54(2):35-36. 被引量:11
  • 2赵丽静,刘亢丁.血管内皮细胞生长因子治疗缺血性脑卒中的新思路[J].中华临床医师杂志(电子版),2011,5(7):2022-2025. 被引量:11
  • 3苗丽君,王静.Akt与肿瘤的研究进展[J].国外医学(生理病理科学与临床分册),2004,24(5):406-409. 被引量:38
  • 4何春燕,王文健.极低密度脂蛋白与胰岛素抵抗患者的脂代谢紊乱[J].国际内分泌代谢杂志,2006,26(4):260-262. 被引量:2
  • 5Ying Z,Yang J,Liao Wo,et al.Cytosolic FoxO1 isessential for the induction of autophagy and tumoursuppressor activity.Nature cell boil,2010,12(7):665-75.
  • 6Matsumoto M,Han S,Kitamura T,et al.Dual role oftranscription factor FoxO1 in controlling hepatic insulinsensitivity and lipid metabolism.J Clin Invest,2006,116(9):2464-72.
  • 7Meur G,Qian Q,da Silva Xavier G,et al.Nucleo-cytosolic shuttling of FoxO1 directly regulates mouse Ins2but not Ins1 gene expression in pancreaticβcells(MIN6).J Biol Chem,2011,286(15):13647-56.
  • 8Brikenkamp KU,Cofer PJ.FOXO transcription factors asregulators of immune homeostasis:molecules to die for?JImmunol,2003,17l(4):1623-9.
  • 9Junger MA,Rintelen F,Stocker H,et al.The DrosophilaForkhead transcription factor FOXO mediates thereduction in cell number associated with reduced insulinsignaling,J Biol,2003,2(3):20.
  • 10Nakae J,Kitamura T,Kitamura Y,et al.The forkheadtranscription factor Foxo1 regulates adipocyte differentia-tion.Dev Cell,2003,4(1):119-29.

引证文献7

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部